Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 169 found
From 1 References


Babiceanu et al 2016, Nucleic Acids Res
  Nonneoplastic hematologic disorder/lesion Lymph node
ADSL/SGSM3
t(22;22)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
ADSL/SGSM3
t(22;22)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Testis
ADSL/SGSM3
t(22;22)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Skin
ADSL/SGSM3
t(22;22)(q13;q13)
  Nonneoplastic hematologic disorder/lesion Spleen
ADSL/SGSM3
t(22;22)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Salivary gland
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Prostate
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Skin
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Kidney
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Liver
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Pancreas
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Testis
AZGP1/GJC3
t(7;7)(q22;q22)
  Nonneoplastic hematologic disorder/lesion Lymph node
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Skin
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Thyroid
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic mesenchymal disorder/lesion Heart
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic hematologic disorder/lesion Lymph node
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Bladder
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Thyroid
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic hematologic disorder/lesion Spleen
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Oesophagus
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Skin
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Adrenal
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Testis
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Lung
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic hematologic disorder/lesion
CTBS/GNG5
t(1;1)(p22;p22)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Skin
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Adrenal
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Oesophagus
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Thyroid
CTSC/RAB38
t(11;11)(q14;q14)
  Nonneoplastic hematologic disorder/lesion Lymph node
CTSC/RAB38
t(11;11)(q14;q14)
  Nonneoplastic mesenchymal disorder/lesion Heart
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Bladder
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Thyroid
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Skin
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Stomach
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Adrenal
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic hematologic disorder/lesion
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic epithelial disorder/lesion Testis
EEF1DP3/FRY
t(13;13)(q13;q13)
  Nonneoplastic hematologic disorder/lesion Lymph node
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Thyroid
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Skin
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Oesophagus
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Ovary
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
FAM175A/HELQ
t(4;4)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Testis
GKAP1/KIF27
t(9;9)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Prostate
GKAP1/KIF27
t(9;9)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Thyroid
GKAP1/KIF27
t(9;9)(q21;q21)
  Nonneoplastic hematologic disorder/lesion Lymph node
GKAP1/KIF27
t(9;9)(q21;q21)
  Nonneoplastic hematologic disorder/lesion Lymph node
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Thyroid
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Testis
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Bladder
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Skin
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic hematologic disorder/lesion
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
HACL1/COLQ
t(3;3)(p25;p25)
  Nonneoplastic epithelial disorder/lesion Thyroid
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic hematologic disorder/lesion Lymph node
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Adrenal
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Oesophagus
KANSL1/ARL17A
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Thyroid
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic hematologic disorder/lesion Lymph node
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Adrenal
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Skin
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Oesophagus
KANSL1/ARL17B
t(17;17)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Thyroid
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic epithelial disorder/lesion Lung
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic epithelial disorder/lesion Testis
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic epithelial disorder/lesion Oesophagus
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic epithelial disorder/lesion Adrenal
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic hematologic disorder/lesion Lymph node
METTL10/FAM53B
t(10;10)(q26;q26)
  Nonneoplastic epithelial disorder/lesion Thyroid
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Skin
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Oesophagus
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic hematologic disorder/lesion
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Bladder
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
NOTCH2NL/NBPF10
t(1;1)(q21;q21)
  Nonneoplastic epithelial disorder/lesion Salivary gland
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Thyroid
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Gallbladder/Biliary system
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Bladder
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic hematologic disorder/lesion
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Testis
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic hematologic disorder/lesion Lymph node
PRKAA1/TTC33
t(5;5)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Bladder
SCNN1A/TNFRSF1A
t(12;12)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Lung
SCNN1A/TNFRSF1A
t(12;12)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Stomach
SCNN1A/TNFRSF1A
t(12;12)(p13;p13)
  Nonneoplastic hematologic disorder/lesion
SEPT7P2/PSPH
t(7;7)(p11;p12)
  Nonneoplastic epithelial disorder/lesion Small intestine
SEPT7P2/PSPH
t(7;7)(p11;p12)
  Nonneoplastic mesenchymal disorder/lesion Heart
SEPT7P2/PSPH
t(7;7)(p11;p12)

NextPage